DEFA14A ·Filed Apr 29, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine governance filing with no material financial implications. No immediate action required; monitor for any upcoming shareholder meeting details.
Final — all horizons settled through T+60d
OLMA ▼ -16.66% at T+60d
NEUTRAL call ✗ call lost -16.66% · α vs SPY -19.76% · entry $14.41 → $12.01
T+1d
-0.62%
call -0.62% · α -0.84%
$14.32
settled 5mo ago
T+5d
+5.00%
call +5.00% · α +3.27%
$15.13
settled 5mo ago
T+20d
-8.47%
call -8.47% · α -13.69%
$13.19
settled 4mo ago
T+60d
-16.66%
call -16.66% · α -19.76%
$12.01
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Olema Pharmaceuticals filed DEFA14A additional definitive proxy solicitation materials. The only substantive recent event is the appointment of Dr. Prakash Raman as an independent Class II director, which is a routine governance change with no material financial impact.
Key Facts
- Filed additional definitive proxy materials (DEFA14A)
- Board appointed Dr. Prakash Raman as independent Class II director on April 27, 2026
- Director granted standard stock options: 24,150 shares (3-year vest) and 2,911 shares (vests June 2026)
Financial Impact
No material financial impact; routine director compensation with standard option grants.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (19 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-191960 |
| Document: 0001193125-26-191960-index-headers.html | 0001193125-26-191960 |
| Document: 0001193125-26-191960-index.html | 0001193125-26-191960 |
| Document: 0001193125-26-191960.txt | 0001193125-26-191960 |
13 reports for OLMA
25% Hit rate best @ T+1▲ +12.65%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 8-K | $10.43 $10.36 | ▼ −0.67% | ▲ +0.39% | $8.24 (−21.00%) |
Aug 10, 2026 7w ago | Press Release | $10.43 $10.36 | ▼ −0.67% | ▲ +0.39% | $8.24 (−21.00%) |
Aug 9, 2026 7w ago | Institutional Cluster | $11.94 $10.99 | ▲ +8.00% | ▲ +7.08% | $8.24 (+30.99%) |
May 26, 2026 18w ago | 8-K | $13.55 $11.46 | ▼ −15.42% | ▼ −13.48% | $8.24 (−39.19%) |
May 26, 2026 18w ago | Press Release | $13.55 $11.46 | ▼ −15.42% | ▼ −13.48% | $8.24 (−39.19%) |
May 21, 2026 19w ago | 8-K | $13.68 $10.19 | ▼ −25.51% | ▼ −24.10% | $8.24 (−39.77%) |
May 21, 2026 19w ago | Press Release | $13.68 $10.19 | ▼ −25.51% | ▼ −24.10% | $8.24 (−39.77%) |
May 12, 2026 20w ago | 8-K | $13.97 $9.82 | ▼ −29.71% | ▼ −27.98% | $8.24 (−41.02%) |
May 12, 2026 20w ago | Press Release | $13.97 $9.82 | ▼ −29.71% | ▼ −27.98% | $8.24 (−41.02%) |
Apr 29, 2026 22w ago | DEFA14A | $14.41 $13.19 | ▼ −8.47% | ▼ −13.69% | $8.24 (−42.82%) |
Showing 10 of 13
US Market Status
Market Open — Closes in 4h 32m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access